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verexpression studies have identiﬁed X-linked
inhibitor of apoptosis protein (XIAP) as a potent
inhibitor of caspases. However, the exact func-
tion of endogenous XIAP in regulating mammalian
apoptosis is less clear. Endogenous XIAP strictly regulates
cytochrome 
 
c
 
–dependent caspase activation in sympa-
thetic neurons but not in many mitotic cells. We report that
postmitotic cardiomyocytes, unlike ﬁbroblasts, are remark-
ably resistant to cytosolic microinjection of cytochrome 
 
c
 
.
O
 
The cardiomyocyte resistance to cytochrome 
 
c
 
 is mediated
by endogenous XIAP, as XIAP-deﬁcient cardiomyocytes die
rapidly with cytosolic cytochrome 
 
c
 
 alone. Importantly, we
found that cardiomyocytes, like neurons, have markedly
reduced Apaf-1 levels and that this decrease in Apaf-1 is
directly linked to the tight regulation of caspase activation
by XIAP. These data identify an important function of XIAP
in cardiomyocytes and point to a striking similarity in the
regulation of apoptosis in postmitotic cells.
 
Introduction
 
Although studies in cell lines have identified the main compo-
nents of the mammalian apoptotic pathway, the differences in
the regulation of apoptosis in various primary cells remain
largely unexplored. The critical executors of apoptosis are the
caspase proteases (Fuentes-Prior and Salvesen, 2004). A major
mechanism by which caspases become activated during apop-
tosis in mammalian cells involves the convergence of signaling
pathways at the mitochondria to induce the release of cyto-
chrome 
 
c
 
. Once in the cytosol, cytochrome 
 
c
 
 binds to Apaf-1 to
induce its oligomerization and recruit procaspase-9 to form the
apoptosome complex. This results in the activation of caspase-
9, which then activates caspase-3, which in turn cleaves vari-
ous cellular proteins to induce rapid cell death (Hengartner,
2000; Wang, 2001).
The cytochrome 
 
c
 
–dependent caspase activation pathway
can be regulated by the inhibitor of apoptosis family of proteins
(IAP; Salvesen and Duckett, 2002). These proteins, which in-
clude X-linked IAP (XIAP), cellular IAP (cIAP) 1 and 2, and
neuronal apoptosis inhibitory protein, can block apoptosis by
directly binding to activated caspases. Addition of purified
IAPs blocks cytochrome 
 
c
 
–mediated caspase activation in
vitro, and overexpression of IAPs inhibits caspase activation
and apoptosis in a variety of cells (Deveraux and Reed, 1999).
However, endogenous IAPs appear to be far more restricted in
their ability to regulate apoptosis after cytochrome 
 
c
 
 in mam-
malian cells. In many mitotic cells, such as HeLa cells, human
embryonic kidney 293 cells, and primary fibroblasts, cytosolic
accumulation of cytochrome 
 
c
 
 alone is sufficient to induce
rapid caspase activation and apoptosis. In these cells, addition
of cytochrome 
 
c
 
 to cytosolic lysates triggers robust caspase
activation in vitro (Liu et al., 1996; Kluck et al., 1997; Hu et
al., 1999), and microinjection of cytochrome 
 
c
 
 is sufficient to
induce rapid cell death in intact cells (Li et al., 1997; Brustugun
et al., 1998; Juin et al., 1999; Chang et al., 2000). These results
argue against a strict postcytochrome 
 
c
 
 regulation of apoptosis
by IAPs in mitotic cells. In contrast, neonatal sympathetic
neurons are remarkably resistant to cytosolic microinjection
of cytochrome 
 
c
 
 (Deshmukh and Johnson, 1998; Neame et al.,
1998). In these neurons, the resistance to cytochrome 
 
c
 
 is at-
tributable to strict control of caspase activation by endogenous
XIAP. Unlike wild-type neurons, XIAP-deficient sympathetic
neurons die rapidly with cytosolic cytochrome 
 
c
 
 alone (Potts et
al., 2003).
The selective ability of endogenous XIAP to strictly reg-
ulate apoptosis after cytochrome 
 
c
 
 in sympathetic neurons but
not in many mitotic cells is not attributable to differences in
XIAP expression levels. Instead, as we recently reported, neu-
ronal differentiation is accompanied by a marked reduction in
Apaf-1 levels, resulting in a significant decrease in apoptosome
activity (Wright et al., 2004). Importantly, this decrease in
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Apaf-1 is directly linked to the increased ability of endogenous
XIAP to inhibit apoptosis in neurons. Restoring Apaf-1 levels
is sufficient to eliminate XIAP’s strict regulation of caspases
and permit cytochrome 
 
c
 
 alone to induce rapid apoptosis in
sympathetic neurons (Wright et al., 2004). Thus, the effective-
ness of XIAP in regulating apoptosis in mammalian cells can
be set simply by modulating Apaf-1 activity, without the need
to directly affect XIAP expression or function.
An increased control of apoptosis is advantageous for
neurons, as they are postmitotic and last for the life of organ-
isms. For example, the strict regulation of caspase activation by
XIAP may protect neurons from accidentally undergoing apop-
tosis if cytochrome 
 
c
 
 is released from damaged mitochondria.
Arguably, such an increased regulation of apoptosis could
be evolutionarily beneficial for other terminally differentiated
cells that survive the life of organisms as well.
To test this hypothesis, we examined whether cyto-
chrome 
 
c
 
–mediated caspase activation is strictly regulated in
primary cardiomyocytes. Cardiomyocytes, like neurons, are
postmitotic cells with limited regenerative potential that last
for the life of organisms (Anversa et al., 2002). Conse-
quently, apoptotic death of cardiomyocytes is a significant
factor that contributes to heart failure (Gill et al., 2002; Clerk
et al., 2003; Foo et al., 2005; Garg et al., 2005). Our results show
that because of low Apaf-1 levels, cytochrome 
 
c
 
–dependent
caspase activation is strictly regulated by endogenous XIAP
in cardiomyocytes, just as in sympathetic neurons. The selec-
tive ability of endogenous XIAP to tightly regulate caspase
activation in cardiomyocytes and neurons points to a com-
mon mechanism that ensures the long-term survival of post-
mitotic cells.
 
Results and discussion
 
Cardiomyocytes are resistant to 
cytosolic microinjection of cytochrome 
 
c
 
Sympathetic neurons, unlike many mitotic cells, are remark-
ably resistant to cytosolic cytochrome 
 
c
 
. To determine whether
terminally differentiated cardiomyocytes display the same re-
sistance, we microinjected primary mouse neonatal cardiomyo-
cytes with cytochrome 
 
c
 
. As a control, we also microinjected
fibroblasts isolated from the same animals. Bovine cytosolic
cytochrome 
 
c
 
 alone was sufficient to induce rapid cell death in
fibroblasts, with 90% of fibroblasts dying within 30 min of the
injections (Fig. 1). In contrast, bovine cytochrome 
 
c
 
 alone was
incapable of inducing cell death in cardiomyocytes, as 
 
 
 
90%
of cardiomyocytes remained viable even 10 h after the cyto-
chrome 
 
c
 
 injections (Fig. 1). Control injections with yeast
cytochrome 
 
c
 
, which is incapable of activating caspases
(Ellerby et al., 1997), did not induce death in either fibroblasts
or cardiomyocytes. Thus, neonatal cardiomyocytes, just like
sympathetic neurons, were markedly resistant to cytosolic
injection of cytochrome 
 
c
 
.
Western analysis indicated that the neonatal cardiomyo-
cytes expressed Apaf-1, caspase-9, and caspase-3 (Fig. 2 A).
This result argues against the possibility that cytochrome 
 
c
 
 was
unable to induce death in cardiomyocytes because of a defi-
ciency of the core components of the apoptotic machinery.
In sympathetic neurons, cytochrome 
 
c
 
–induced caspase activa-
tion is tightly regulated by endogenous IAPs. Addition of exog-
enous Smac, which inhibits IAPs, overcomes the resistance to
cytochrome 
 
c
 
 and permits apoptosis to occur in neurons (Desh-
mukh et al., 2002; Potts et al., 2003). To examine whether the
cardiomyocyte resistance to cytochrome 
 
c
 
 was also attributable
to a stringent regulation by endogenous IAPs, we examined
whether injection of excess Smac permitted cytochrome 
 
c
 
 to ac-
tivate apoptosis in cardiomyocytes. Coinjection of cytochrome 
 
c
 
and mature Smac, but neither alone, was remarkably effective in
inducing death in cardiomyocytes (Fig. 2 B). To confirm that
exogenous Smac permitted cytochrome 
 
c
 
 to induce apoptosis by
inhibiting IAPs in cardiomyocytes, we examined whether a mu-
tant Smac protein that cannot inhibit IAPs (Chai et al., 2000)
was capable of permitting cytochrome 
 
c
 
 to induce death. We
found that unlike wild-type Ala-Val-Pro-Ile (AVPI)–Smac, the
mutant Met-Val-Pro-Ile (MVPI)–Smac was incapable of coop-
erating with cytochrome 
 
c
 
 to induce death in cardiomyocytes
(Fig. 2 C). We also confirmed that the death induced by injection
of cytochrome 
 
c
 
 and AVPI-Smac occurred as a consequence of
caspase activation. Addition of the pan caspase inhibitor zVAD-
FMK completely blocked the cardiomyocyte death induced by
cytochrome 
 
c
 
 and Smac (Fig. 2 C). Together, these results show
that the components of the apoptosome are present and func-
tional in cardiomyocytes but only become permissive for
apoptosis if the activity of IAPs is blocked.
Figure 1. Cytosolic microinjection of cytochrome c induces death in fibro-
blasts but not cardiomyocytes. Neonatal rat cardiomyocytes and dermal
fibroblasts were microinjected with 25  g/ l of bovine or yeast cyto-
chrome c, and cell survival (using morphological criteria) was assessed at
multiple times after the injections. (A) Phase-contrast and fluorescence pho-
tographs of the cells 3 h after the injections of cytochrome c. The injected
cells (arrows) were identified by the presence of rhodamine dextran coin-
jected with the cytochrome c. (B) Quantitation of cell survival. Data shown
are the mean   SEM of three independent experiments. 
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Strict regulation of cytochrome 
 
c
 
–induced 
apoptosis in cardiomyocytes by 
endogenous XIAP
 
Western analysis indicated that cardiomyocytes express multiple
IAPs, including XIAP, c-IAP-1, and c-IAP-2 (Fig. 2 A). Despite
the expression of multiple IAPs in sympathetic neurons, the
removal of XIAP alone is sufficient to permit cytochrome
 
c
 
–dependent caspase activation in neurons (Potts et al., 2003).
To determine whether endogenous XIAP is an important reg-
ulator of caspase activation in cardiomyocytes, we examined
the ability of cytochrome 
 
c
 
 to induce death in cardiomyocytes
isolated from XIAP-deficient mice (Harlin et al., 2001). In
contrast to wild-type cardiomyocytes that are resistant to cy-
tochrome 
 
c
 
, the XIAP-deficient cardiomyocytes were strik-
ingly permissive and died with cytosolic microinjection of
cytochrome 
 
c
 
 alone (Fig. 3 A). 50% of XIAP-deficient cardio-
myocytes were dead within 2 h of cytochrome 
 
c
 
 injections,
and 
 
 
 
15% remained alive 9 h after the injections. In contrast,
80% of wild-type cardiomyocytes remained viable even 9 h
after cytochrome 
 
c
 
 injections (Fig. 3 B). The XIAP-deficient
cardiomyocytes were not generally susceptible to microinjec-
tion per se, as control injections with yeast cytochrome 
 
c
 
 did
not induce death in these cells.
Thus, despite the rather ubiquitous expression of XIAP in
mammalian cells, these results identify cardiomyocytes as only
the second mammalian cell type in which endogenous XIAP ex-
erts a strict control over cytochrome 
 
c
 
–dependent apoptosis.
However, we cannot exclude the possibility that XIAP defi-
ciency may simply lower the overall threshold of IAPs below a
level that allows cytochrome 
 
c
 
 to activate caspases in these cells.
 
Markedly reduced Apaf-1 levels set the 
threshold for stringent regulation of 
apoptosis by XIAP in cardiomyocytes
 
We recently reported that the effectiveness of endogenous
XIAP to regulate apoptosis is inversely coupled to the Apaf-1–
dependent apoptosome activity in cells (Wright et al., 2004).
To determine whether the strict control of cytochrome 
 
c
 
–medi-
ated death by XIAP in cardiomyocytes is regulated by a similar
mechanism, we examined the levels of Apaf-1. As a compari-
son, we also examined Apaf-1 levels in dermal fibroblasts. Un-
like cardiomyocytes, fibroblasts show no strict regulation by
endogenous XIAP and die with injection of cytochrome 
 
c
 
 alone
(Fig. 1). We found that the level of Apaf-1 protein in cardiomyo-
cytes was strikingly reduced to 
 
 
 
25% of the Apaf-1 levels
found in fibroblasts (Fig. 4). This decrease in Apaf-1 was not
an artifact of maintaining cardiomyocytes in culture for 6–8 d,
as similar low levels of Apaf-1 were seen in cardiomyocytes
immediately after their isolation (Fig. S1 A, available at http://
www.jcb.org/cgi/content/full/jcb.200504082/DC1).
We examined whether this marked difference in Apaf-1
seen between cardiomyocytes and fibroblasts was reflective
of a general decrease in the apoptosome components in cardio-
myocytes. However, we found no differences in caspase-9
levels between cardiomyocytes and fibroblasts. Because E2F1
has been identified as a transcriptional regulator of Apaf-1
(Moroni et al., 2001), the reduced activity of E2F1 in termi-
nally differentiated cardiomyocytes (Flink et al., 1998) is
likely to contribute to the marked reduction in Apaf-1 levels
in these cells.
To determine whether the low Apaf-1 expression in
cardiomyocytes was indeed responsible for the strict regulation
of caspase activation by XIAP, we examined whether elevating
the levels of Apaf-1 in these cells rendered XIAP ineffective.
Cardiomyocytes were transfected with plasmids expressing
GFP and either Apaf-1 or vector alone. After 24 h to allow for
expression, the transfected cardiomyocytes (GFP positive)
were injected with cytochrome 
 
c
 
 to examine the ability of cy-
tosolic cytochrome 
 
c
 
 to induce apoptosis. Increasing Apaf-1
levels was highly effective in permitting cytochrome 
 
c
 
 alone
Figure 2. Cardiomyocyte resistance to cytochrome c can be overcome
with the exogenous addition of the IAP inhibitor Smac. (A) Western blots
showing that the rat cardiomyocyte cultures express the core apoptotic
components (Apaf-1, caspase-9, and caspase-3) and various IAPs (XIAP,
cIAP-1, and cIAP-2). LDH and Troponin I are shown as controls. (B) Rat
cardiomyocytes were microinjected with 25  g/ l of bovine cytochrome c,
1  g/ l of wild-type mature Smac, or both, and cell survival was assessed
at multiple times after the injections. (C) Rat cardiomyocytes were injected
with 25  g/ l of bovine cytochrome c and 1  g/ l of either mature wild-
type AVPI-Smac or mature mutant MVPI-Smac in the presence or absence
of 50  M of the pan caspase inhibitor zVAD-FMK. Cell survival was as-
sessed at multiple times after the injections. Data shown are the mean  
SEM of three independent experiments.
Figure 3. XIAP-deficient cardiomyocytes die with injection of cytochrome c.
Cardiomyocytes isolated from XIAP-deficient ( / ) or wild-type ( / ) lit-
termate mice were microinjected with 25  g/ l of bovine cytochrome c.
As a control, XIAP-deficient cardiomyocytes were also injected with 25
 g/ l of yeast cytochrome c. (A) Phase-contrast and fluorescence photo-
graphs of representative cells. Arrows mark the injected cells, identified by
coinjection of rhodamine dextran along with cytochrome c. (B) Quantita-
tion of cell survival at multiple times after the injections. Data shown are
the mean   SEM of three independent experiments. 
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to induce cell death in cardiomyocytes (Fig. 5). Apaf-1 over-
expression alone did not affect survival, as 
 
 
 
90% of Apaf-
1–expressing cardiomyocytes remained alive when injected
with the control, yeast cytochrome 
 
c
 
. Also, this effect was se-
lective for Apaf-1, as overexpression of procaspase-9, the other
apoptosome component, did not overcome XIAP inhibition
(Fig. 5). Thus, the ability of endogenous XIAP to strictly reg-
ulate apoptosis in cardiomyocytes was coupled to the reduced
Apaf-1 levels.
Our observation that cytosolic cytochrome 
 
c
 
 was insuffi-
cient to induce apoptosis in cardiomyocytes is consistent with
studies showing substantial translocation of cytochrome 
 
c to
the cytosol without much detectable apoptosis in human cardio-
myopathic hearts (Narula et al., 1999; Scheubel et al., 2002).
Likewise, a recent study found staurosporine treatment capa-
ble of inducing cytochrome c release but not apoptosis in car-
diomyocytes (Sanchis et al., 2003). However, this study found
no detectable Apaf-1 expression in cardiomyocytes and con-
cluded that the cardiomyocyte resistance to cytochrome c
occurred because these cells lacked Apaf-1 (Sanchis et al.,
2003). In contrast, we report here that cardiomyocytes express
low levels of Apaf-1, and a consequence of this low Apaf-1
activity is the engagement of a strict control of caspase activa-
tion by endogenous XIAP. Using single cell microinjections of
cardiomyocytes from wild-type and XIAP-deficient mice, we
show that cytosolic cytochrome c is fully capable of inducing
apoptosis in cardiomyocytes, provided XIAP’s inhibition of
caspases is relieved.
The overall similarities in the mechanisms governing the
strict postcytochrome c regulation of apoptosis in cardiomyo-
cytes and sympathetic neurons are striking (Potts et al., 2003;
Wright et al., 2004). In both of these postmitotic cell types, but
not in mitotic fibroblasts, endogenous XIAP is highly effective
in controlling cytochrome c–dependent caspase activation.
In both, this occurs as a consequence of markedly reduced
Apaf-1 expression. Although cardiomyocytes and sympathetic
neurons have very different physiological and morphological
properties, both cell types have limited regenerative potential
and require long-term survival. Apaf-1 expression is reduced
even further in adult, as compared with neonatal, heart (Fig.
S1 B) and brain tissues (Yakovlev et al., 2001). Low Apaf-1
expression is also seen in other tissues, such as liver and skel-
etal muscle, that contain a substantial number of postmitotic
cells (Fig. S2, available at http://www.jcb.org/cgi/content/full/
jcb.200504082/DC1; Burgess et al., 1999). Together, our data
indicate that terminal differentiation triggers a marked reduction
in Apaf-1 levels and the consequent engagement of a highly
effective XIAP-mediated safety brake to ensure the long-term
survival of postmitotic cells.
Materials and methods
Reagents
All reagents were purchased from Sigma-Aldrich or Fisher Scientific, unless
otherwise stated. The Apaf-1 cDNA was a gift from G. Nuñez (University of
Michigan, Ann Arbor, MI), and the caspase-9 cDNA was a gift from C. Du
(Stowers Institute, Kansas City, MO). Recombinant AVPI- and MVPI-Smac
proteins were generated as previously described (Potts et al., 2003).
Primary cardiomyocyte and fibroblast cultures
Primary cardiomyocyte cultures were isolated from postnatal day 0–1 rats
or mice by using the Worthington neonatal cardiomyocyte isolation system
(Worthington Biochemical Corp.) following the manufacturer’s instructions.
A preplating step (for 2 h) was included to reduce the number of fibroblasts
Figure 4. Apaf-1 but not caspase-9 levels are markedly reduced in
cardiomyocytes in comparison to fibroblasts. (A) Western blots showing
levels of Apaf-1 and caspase-9 proteins (and LDH and Troponin I as con-
trols) in cultures of rat dermal fibroblasts and cardiomyocytes. (B) Quanti-
tation of the data in which Apaf-1 and caspase-9 protein levels detected in
cardiomyocyte cultures are expressed as a percentage of the levels (normal-
ized to LDH) seen in fibroblast cultures. Data shown are the mean   SEM
of three independent experiments.
Figure 5. Restoring Apaf-1 levels eliminates the strict control of XIAP and
permits cytochrome c to induce apoptosis in cardiomyocytes. Rat cardio-
myocytes were transfected with plasmids expressing GFP alone (Vector/
GFP), Apaf-1 and GFP (Apaf-1/GFP), or procaspase-9 and GFP (caspase-9/
GFP). After 24 h, the transfected cells (identifiable by GFP expression)
were microinjected with 25  g/ l of bovine or yeast cytochrome c and
rhodamine dextran (Cyt c/Rhod). (A) Fluorescence photographs (for the
GFP- or Rhodamine-selective channels) of representative cells taken 2 h af-
ter the cytochrome c injections. Arrows point to the GFP-positive cells that
were injected with cytochrome c and rhodamine. (B) Quantitation of cell
survival (2 h after the injections) for the various conditions. Data shown
are the mean   SEM of three independent experiments.XIAP FUNCTION DURING CARDIOMYOCYTE APOPTOSIS • POTTS ET AL. 929
in the cultures. Cells were then plated on laminin-coated plates in MEM
with Earle’s salt supplemented with 2 mM glutamine, 10% horse serum,
5% FBS, 100  g/ml penicillin, and 100  g/ml streptomycin. Experiments
were performed on cells 6–8 d after plating.
Primary dermal fibroblasts were isolated from postnatal day 0–1
rats as follows. The dorsal skin was removed and treated with 1 mg/ml
collagenase and 2.5 mg/ml trypsin for 1 h each at 37 C. Tissue was then
triturated, and the dissociated cells were plated in DME supplemented
with 10% FBS, 100  g/ml penicillin, and 100  g/ml streptomycin. Cells
were passaged once before experiments.
Microinjections and quantitation of cell survival
Cells were microinjected on 35-mm plates using Femtotip II needles (Ep-
pendorf, Inc.) or needles pulled on a Flaming-Brown horizontal micropi-
pette puller (Sutter Instrument Co.) and a Narashigi micromanipulator
mounted on an inverted fluorescence microscope (Leica). Between 50
and 150 cells were injected for each condition in these experiments.
The microinjection solution contained 100 mM KCl, 10 mM KPi, pH 7.4,
and 8 mg/ml rhodamine dextran, with 25  g/ l bovine or yeast cy-
tochrome c and 1  g/ l AVPI- or MVPI-Smac in some experiments as
indicated. After microinjections, viable cells were identified as those
rhodamine-positive cells that continued to beat (for cardiomyocytes) and
had an intact morphology. The dead cells appeared rounded and often
with disintegrated membranes.
Transfections
Neonatal cardiomyocytes were transfected with Lipofectamine 2000 (Invi-
trogen) according to the manufacturer’s instructions. In brief, cells were
switched to antibiotic-free media and transfected with 2.5  g DNA (0.6
 g EGFP and 1.9  g pCDNA3 plasmids expressing Apaf-1, procaspase-9,
or vector alone).
Western blots
Western blots were performed as described previously (Potts et al.,
2003). Primary antibodies used were as follows: anti-XIAP (R&D Systems),
anti–cIAP-1 (R&D Systems), anti–cIAP-2 (R&D Systems), anti–caspase-9
(MBL International Corporation), anti–procaspase-3 (Cell Signaling
Technology), anti–Apaf-1 (Alexis Biochemicals Corp.), anti–lactate de-
hydrogenase (LDH; Rockland Immunochemicals), and anti–Troponin I
(Chemicon). Anti–mouse/rabbit HRP-conjugated secondary antibodies
were purchased from Pierce Chemical Co. Proteins were detected using
ECL-Plus detection system. Protein levels were quantified by scanning
blots on a Typhoon scanner (GE Healthcare) and analysis with ImageQuant
software (GE Healthcare).
XIAP  /  mice
The XIAP-deficient mice were obtained from C. Thompson (University of
Pennsylvania, Philadelphia, PA; Harlin et al., 2001). Our procedure for
genotyping these mice was described previously (Potts et al., 2003).
Image acquisition and processing
All images were acquired by a digital, black-and-white, charge-coupled
device camera (ORCA-ER; Hamamatsu) mounted on an inverted fluores-
cence microscope (DMIRE 2; Leica). Images were taken with a 40  oil
immersion objective. The fluorescence images were taken with a tetra-
methylrhodamine-isothiocyanate DiL HQ filter set (rhodamine; Chroma
Technology Corp.). The image acquisition software was Metamorph 5.0
(Universal Imaging Corp.). Images were scaled down and cropped in
Photoshop (Adobe) to prepare the final figures.
Online supplemental material
Fig. S1 A shows that levels of Apaf-1 are not affected by time in culture, and
Fig. S1 B shows that Apaf-1 levels are further decreased in adult versus neo-
natal cardiomyocytes. Fig. S2 shows the expression profile of Apaf-1 in var-
ious tissues from adult rat. Online supplemental material is available at http:
//www.jcb.org/cgi/content/full/jcb.200504082/DC1.
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